← Eichor
Study identifier: NCT07138872 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Hemodynamic Effects of Surgical Position in Prone vs. Supine Percutaneous Nephrolithotomy

Condition: Percutaneous Nephrolithotomy (PCNL) · Surgical Positioning · Prone Position  ·  Sponsor: Gaziosmanpasa Research and Education Hospital

PhaseNA
Planned participants84
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

This prospective, randomized controlled study evaluates the hemodynamic effects of prone and supine positions during percutaneous nephrolithotomy (PNL) for large kidney stones. Surgical position may influence intraoperative and postoperative hemodynamic stability. Prone positioning can increase intrathoracic pressure and reduce venous return, whereas supine positioning may provide greater hemodynamic stability. A total of 84 patients will be randomized to undergo PNL in prone or supine positions. Primary outcomes include changes in hemodynamic parameters during surgery. Results may guide surgical position selection, especially in patients with potential hemodynamic risk.

This description comes directly from the study's public registry record.

Talk to the study team

ARİF BURAK KEÇEBAŞ, UROLOGY CLINIC DOCTOR  ·  +90 5412659978  ·  arifkecebas@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Gaziosmanpaşa Training and Research HospitalIstanbul, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07138872